Skip to main content

Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia

Abstract

Although pneumonia has been a hallmark of Mycoplasma pneumoniae infection, it has been revealed that this infection can cause a number of extrapulmonary manifestations in the absence of pneumonia. While the host immune response has been implicated in the pathomechanism of pneumonia, the pathomechanisms of extrapulmonary manifestations remain largely unknown. It is proposed in this review that extrapulmonary manifestations due to M. pneumoniae infection can be classified into three categories; the first is a direct type in which inflammatory cytokines locally induced by lipoproteins contained in the bacterial cell membrane must play a role, the second is an indirect type in which immune modulation such as autoimmunity through cross-reaction between the bacterial cell components and human cells must play a role, and the third is a vascular occlusion type in which vasculitis and/or thrombosis with or without systemic hypercoagulable state induced by the bacterium must play a role. Based on this classification, a literature review was carried out for extrapulmonary manifestations due to M. pneumoniae infection with special reference to pneumonia, including cardiovascular, dermatological, digestive organ, hematological/hematopoietic system, musculoskeletal, sensory organ, and urogenital tract manifestations. Consequently, most extrapulmonary manifestations due to M. pneumoniae infection can be reasonably classified into and explained by one of the three types of pathomechanisms mentioned above. Noticeably in this review, Kawasaki disease and infectious mononucleosis in association with M. pneumoniae infection, which are not unusual in Japan but have seldom been reported from Western countries, are included in the panel of extrapulmonary manifestations due to M. pneumoniae infection.

This is a preview of subscription content, access via your institution.

References

  1. Narita M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol. 2009;41:159–66.

    Article  PubMed  Google Scholar 

  2. Martire B, Foti C, Cassano N, Buquicchio R, Del Vecchio GC, De Mattia D. Persistent B-cell lymphopenia, multiorgan disease, and erythema multiforme caused by Mycoplasma pneumoniae infection. Pediatr Dermatol. 2005;22:558–60.

    Article  PubMed  Google Scholar 

  3. Kountouras D, Deutsch M, Emmanuel T, Georgiadis G, Koskinas J. Fulminant Mycoplasma pneumoniae infection with multi-organ involvement: a case report. Eur J Int Med. 2003;14:329–31.

    Article  Google Scholar 

  4. Daxböck F, Brunner G, Popper H, Krause R, Schmid K, Krejs GJ, et al. A case of lung transplantation following Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 2002;21:318–22.

    Article  PubMed  Google Scholar 

  5. Koletsky RJ, Weinstein AJ. Fulminant Mycoplasma pneumoniae infection. Am Rev Respir Dis. 1980;122:491–6.

    CAS  PubMed  Google Scholar 

  6. Pönkä A. Carditis associated with Mycoplasma pneumoniae infection. Acta Med Scand. 1979;206:77–86.

    PubMed  Google Scholar 

  7. Sands MJ Jr, Satz JE, Turner WE Jr, Soloff LA. Pericarditis and perimyocarditis associated with active Mycoplasma pneumoniae infection. Ann Intern Med. 1977;86:544–8.

    PubMed  Google Scholar 

  8. Maresh H, Klimek JJ, Quintiliani R. Myocardial dysfunction and hemolytic anemia in a patient with Mycoplasma pneumoniae infection. Chest. 1977;71:410–3.

    Article  CAS  PubMed  Google Scholar 

  9. Chergui K, Fourme T, Veillard-Baron A, Loubieres Y, Voyer C, Jardin F. Mycoplasma pneumoniae and second-degree heart block. Clin Infect Dis. 1998;27:1534–5.

    Article  CAS  PubMed  Google Scholar 

  10. Umemoto M, Fujii I, Take H. Advanced atrioventricular block associated with atrial tachycardia caused by Mycoplasma pneumoniae infection. Acta Paediatr Jpn. 1995;37:518–20.

    CAS  PubMed  Google Scholar 

  11. Meseguer MA, Pérez-Molina JA, Fernández-Bustamante J, Gómez R, Martos I, Quero MC. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr Infect Dis J. 1996;15:829–31.

    Article  CAS  PubMed  Google Scholar 

  12. Kenny RT, Li JS, Clyde WA Jr, Wall TC, O’Connor CM, Campbell PT, et al. Mycoplasmal pericarditis: evidence of invasive disease. Clin Infect Dis. 1993;17(Suppl 1):S58–62.

    Google Scholar 

  13. Naftalin JM, Wellisch G, Kahana Z, Diengott D. Mycoplasma pneumoniae septicemia. J Am Med Assoc. 1974;228:565.

    Article  CAS  Google Scholar 

  14. Szymanski M, Petric M, Saunders FE, Tellier R. Mycoplasma pneumoniae pericarditis demonstrated by polymerase chain reaction and electron microscopy. Clin Infect Dis. 2002;34:e16–7.

    Article  PubMed  Google Scholar 

  15. Scapini JP, Flynn LP, Sciacaluga S, Morales L, Cadario ME. Confirmed Mycoplasma pneumoniae endocarditis. Emerg Infect Dis. 2008;14:1664–5.

    Article  PubMed  Google Scholar 

  16. Farraj RS, McCully RB, Oh JK, Smith TF. Mycoplasma-associated pericarditis. Mayo Clin Proc. 1997;72:33–6.

    Article  CAS  PubMed  Google Scholar 

  17. Leen C, Ling S. Mycoplasma infection and Kawasaki disease. Arch Dis Child. 1996;75:266–7.

    Article  CAS  PubMed  Google Scholar 

  18. Sakai R, Sakaguchi S, Oguchi S, et al. Three cases of Kawasaki disease complicated by Mycoplasma pneumoniae infection. Shonika Rinsyo. 2007;60:1591–6. (Japanese with English abstract).

    Google Scholar 

  19. Wang JN, Wang SM, Liu CC, Wu JM. Mycoplasma pneumoniae infection associated with Kawasaki disease. Acta Paediatr. 2001;90:594–5.

    CAS  PubMed  Google Scholar 

  20. Narita M, Yamada S, Nakayama T, Sawada H, Nakajima M, Sageshima S. Two cases of lymphadenopathy with liver dysfunction due to Mycoplasma pneumoniae infection with mycoplasmal bacteraemia without pneumonia. J Infect. 2001;42:154–6.

    Article  CAS  PubMed  Google Scholar 

  21. Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL. Kawasaki disease: an overview. Curr Opin Infect Dis. 2008;21:263–70.

    Article  PubMed  Google Scholar 

  22. Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis. 1993;17(Suppl 1):S47–51.

    PubMed  Google Scholar 

  23. Schalock PC, Dinulos JGH, Pace N, Schwarzenberger K, Wenger JK. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol. 2006;23:546–55.

    Article  PubMed  Google Scholar 

  24. Léauté-Labrèze C, Lamireau T, Chawki D, Maleville J, Taïeb A. Diagnosis, classification, and management of erythema multiforme and Stevens–Johnson syndrome. Arch Dis Child. 2000;83:347–52.

    Article  PubMed  Google Scholar 

  25. Tay Y-K, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens–Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol. 1996;35:757–60.

    Article  CAS  PubMed  Google Scholar 

  26. Schalock PC, Dinulos JGH. Mycoplasma pneumoniae-induced cutaneous disease. Int J Dermatol. 2009;48:673–81.

    Article  PubMed  Google Scholar 

  27. Meseguer MA, de Rafael L, Vidal ML. Stevens–Johnson syndrome with isolation of Mycoplasma pneumoniae from skin lesions. Eur J Clin Microbiol. 1986;5:167–8.

    Article  CAS  PubMed  Google Scholar 

  28. Lyell A, Gordon AM, Dick HM, Sommerville RG. Mycoplasmas and erythema multiforme. Lancet. 1967;ii:1116–8.

    Article  Google Scholar 

  29. Mulvey JM, Padowitz A, Lindley-Jones M, Nickels R. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35:414–7.

    CAS  PubMed  Google Scholar 

  30. Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol. 1971;8:319–33.

    CAS  PubMed  Google Scholar 

  31. Brunner H, Prescott B, Greenberg H, James WD, Horswood RL, Chanock RM. Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J Infect Dis. 1977;135:524–30.

    CAS  PubMed  Google Scholar 

  32. Kano Y, Mitsuyama Y, Hirahara K, Shiohara T. Mycoplasma pneumoniae infection-induced erythema nodosum, anaphylactoid purpura, and acute urticaria in 3 people in a single family. J Am Acad Dermatol. 2007;57(2 Suppl):S33–5.

    Article  PubMed  Google Scholar 

  33. Ghosh K, Clements GB. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986–1991. J Infect. 1992;25:221–7.

    Article  CAS  PubMed  Google Scholar 

  34. Romero-Gómez M, Otero MA, Sánchez-Muñoz D, Ramírez-Arcos M, Larraona JL, García ES, et al. Acute hepatitis due to Mycoplasma pneumoniae infection without lung involvement in adult patients. J Hepatol. 2006;44:827–8.

    Article  PubMed  Google Scholar 

  35. Daxboeck F, Gattringer R, Mustafa S, Bauer C, Assadian O. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect. 2005;11:507–10.

    Article  CAS  PubMed  Google Scholar 

  36. Grüllich C, Baumert TF, Blum HE. Acute Mycoplasma pneumoniae infection presenting as cholestatic hepatitis. J Clin Microbiol. 2003;41:514–5.

    Article  PubMed  Google Scholar 

  37. Suzuyama Y, Iwasaki H, Izumikawa K, Hara K. Clinical complications of Mycoplasma pneumoniae disease. Other organs. Yale J Biol Med. 1983;56:487–91.

    CAS  PubMed  Google Scholar 

  38. Quioc JJ, Trabut JB, Drouhin F, Malbrunot C, Vallet-Pichard A, Pol S, et al. Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patient. Eur J Gastroenterol Hepatol. 2009;21:220–1.

    Article  PubMed  Google Scholar 

  39. Nagayama Y, Sakurai N, Yamamoto K. Clinical observations of children with pleuropneumonia due to Mycoplasma pneumoniae. Pediatr Pulmonol. 1990;8:182–7.

    Article  CAS  PubMed  Google Scholar 

  40. Van Bever HP, Van Doorn JWD, Demey HE. Adult respiratory distress syndrome associated with Mycoplasma pneumoniae infection. Eur J Pediatr. 1992;151:227–8.

    Article  PubMed  Google Scholar 

  41. Oderda G, Kraut JR. Rising antibody titer to Mycoplasma pneumoniae in acute pancreatitis. Pediatrics. 1980;60:305–6.

    Google Scholar 

  42. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697–728.

    Article  CAS  PubMed  Google Scholar 

  43. Feizi T, Loveless RW. Carbohydrate recognition by Mycoplasma pneumoniae and pathologic consequences. Am J Respir Crit Care Med. 1996;154:5133–6.

    Google Scholar 

  44. Cassell GH, Cole BC. Mycoplasmas as agents of human disease. N Engl J Med. 1981;304:80–7.

    CAS  PubMed  Article  Google Scholar 

  45. Ishida Y, Hiroi K, Tauchi H, Oto Y, Tokuda K, Kida K. Hemophagocytic lymphohistiocytosis secondary to Mycoplasma pneumoniae infection. Pediatr Int. 2004;46:174–7.

    Article  PubMed  Google Scholar 

  46. Mizukane R, Kadota J, Yamaguchi T, Kiya T, Fukushima H, Nakatomi M, et al. An elderly patients with hemophagocytic syndrome due to severe Mycoplasma pneumonia with marked hypercytokinemia. Respiration. 2002;69:87–91.

    Article  PubMed  Google Scholar 

  47. Bruch LA, Jefferson RJ, Pike MG, Gould SJ, Squier W. Mycoplasma pneumoniae infection, meningoencephalitis, and hemophagocytosis. Pediatr Neurol. 2001;25:67–70.

    Article  CAS  PubMed  Google Scholar 

  48. Chyrssanthopoulos C, Eboriadou M, Monti K, Soubassi V, Sava K. Fatal disseminated intravascular coagulation caused by Mycoplasma pneumoniae. Pediatr Infect Dis J. 2001;20:634–5.

    Article  Google Scholar 

  49. Chiou C-C, Liu Y-C, Lin H-H, Hsieh K-S. Mycoplasma pneumoniae infection complicated by lung abscess, pleural effusion, thrombocytopenia and disseminated intravascular coagulation. Pediatr Infect Dis J. 1997;16:327–9.

    Article  CAS  PubMed  Google Scholar 

  50. Fumarola D. Intravascular coagulation and Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 1997;16:1012–3. (Letter to ref. 49).

    Article  CAS  PubMed  Google Scholar 

  51. De Vos M, Van Nimmen L, Baele G. Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection. Acta Haematol. 1974;52:120–5.

    Article  PubMed  Google Scholar 

  52. Nilsson IM, Rausing A, Denneberg T, Christensson P. Intravascular coagulation and acute renal failure in a child with mycoplasma infection. Acta Med Scand. 1971;189:359–65.

    CAS  PubMed  Google Scholar 

  53. Meir EB, Amital H, Levy Y, Kneller A, Bar-Dayan Y, Schoenfeld Y. Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura. Acta Haematol. 2000;103:112–5.

    Article  PubMed  Google Scholar 

  54. Okoli K, Gupta A, Irani F, Kasmani R. Immune thrombocytopenia associated with Mycoplasma pneumoniae infection: a case report and review of literature. Blood Coagul Fibrinolysis. 2009; doi:10.1097/MBC.0b013e32832d6ccb.

  55. Ono T, Yoshida N, Miyazaki S, Hirose M. Infectious mononucleosis-like syndrome associated with Mycoplasma infection. Jpn J Jpn Pediatr Soc. 1991;95:132–6. (Japanese with English abstract).

    Google Scholar 

  56. Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association? Pediatrics. 2007;119:e292–5.

    Article  PubMed  Google Scholar 

  57. Graw-Panzer KD, Verma S, Rao S, Miller ST, Lee H. Venous thrombosis and pulmonary embolism in a child with pneumonia due to Mycoplasma pneumoniae. J Natl Med Assoc. 2009;101:956–8.

    PubMed  Google Scholar 

  58. Snowden N, Wilson PB, Longson M, Pumphrey RSH. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J. 1990;66:356–62.

    Article  CAS  PubMed  Google Scholar 

  59. Franz A, Webster ADB, Furr PM, Taylor-Robison D. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol. 1997;36:661–8.

    Article  CAS  PubMed  Google Scholar 

  60. Taylor-Robinson D, Gumpel JM, Hill A, Swannell AJ. Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypogammaglobulinaemic patient in a survey of patients with inflammatory polyarthritis. Ann Rheum Dis. 1978;37:180–2.

    Article  CAS  PubMed  Google Scholar 

  61. O’Sullivan MVN, Isbel NM, Johnson DW, Rencken K, Byrne S, Graham MM, et al. Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction. Clin Infect Dis. 2004;39:e98–9.

    Article  PubMed  Google Scholar 

  62. Davis CP, Cochran S, Lisse J, Buck G, DiNuzzo AR, Weber T, et al. Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis. Arch Intern Med. 1988;148:969–70.

    Article  CAS  PubMed  Google Scholar 

  63. Chaudhry R, Nisar N, Malhotra P, Kumar A, Chauhan VS. Polymerase chain reaction confirmed Mycoplasma pneumoniae arthritis: a case report. Indian J Pathol Microbiol. 2003;46:433–6.

    PubMed  Google Scholar 

  64. Azumagawa K, Kambara Y, Murata T, Tamai H. Four cases of arthritis associated with Mycoplasma pneumoniae infection. Pediatr Int. 2008;50:511–3.

    Article  PubMed  Google Scholar 

  65. Weng W-C, Peng SS-F, Wang SB, Chou Y-T, Lee W-T. Mycoplasma pneumoniae-associated transverse myelitis and rhabdomyolysis. Pediatr Neurol. 2009;40:128–30.

    Article  PubMed  Google Scholar 

  66. Minami K, Maeda H, Yanagawa T, Suzuki H, Izumi G, Yoshikawa N. Rhabdomyolysis associated with Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2003;22:291–3.

    Article  PubMed  Google Scholar 

  67. Berger RP, Wadowksy RM. Rhabdomyolysis associated with infection by Mycoplasma pneumoniae: a case report. Pediatrics. 2000;105:433–6.

    Article  CAS  PubMed  Google Scholar 

  68. Decaux G, Szyper M, Ectors M, Cornil A, Franken L. Central nervous system complications of Mycoplasma pneumoniae. J Neurol Neurosurg Psychiatry. 1980;43:883–7.

    Article  CAS  PubMed  Google Scholar 

  69. Rothstein TL, Kenny GE. Cranial neuropathy, myeloradiculopathy, and myositis. Complications of Mycoplasma pneumoniae infection. Arch Neurol. 1979;36:476–7.

    CAS  PubMed  Google Scholar 

  70. Waites KB, Atkinson TP. The role of Mycoplasma in upper respiratory infections. Curr Infect Dis Rep. 2009;11:198–206.

    Article  PubMed  Google Scholar 

  71. Sobĕslavský O, Syrůček L, Brůčková M, Abrahamovič M. The etiological role of Mycoplasma pneumoniae in otitis media in children. Pediatrics. 1965;35:652–7.

    PubMed  Google Scholar 

  72. Räty R, Kleemola M. Detection of Mycoplasma pneumoniae by polymerase chain reaction in middle ear fluids from infants with acute otitis media. Pediatr Infect Dis J. 2000;19:666–8.

    Article  PubMed  Google Scholar 

  73. García Berrocal JR, Ramírez-Camacho R, Portero F, Vargas JA. Role of viral and Mycoplasma pneumoniae infection in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2000;120:835–9.

    Article  PubMed  Google Scholar 

  74. Salzman MB, Sood SK, Slavin ML, Rubin LG. Ocular manifestations of Mycoplasma pneumoniae infection. Clin Infect Dis. 1992;14:1137–9.

    CAS  PubMed  Google Scholar 

  75. Weinstein O, Shneck M, Levy J, Lifsbitz T. Bilateral acute anterior uveitis as a presenting symptom of Mycoplasma pneumoniae infection. Can J Ophthalmol. 2006;41:594–5.

    PubMed  Google Scholar 

  76. Sánchez-Vargas FM, Gómez-Duarte OG. Mycoplasma pneumoniae––an emerging extra-pulmonary pathogen. Clin Microbiol Infect. 2008;14:105–15.

    PubMed  Google Scholar 

  77. Siomou E, Kollios KD, Papadimitriou P, Kostoula A, Papadopoulou ZL. Acute nephritis and respiratory tract infection caused by Mycoplasma pneumoniae: case report and review of the literature. Pediatr Infect Dis J. 2003;22:1103–6.

    Article  PubMed  Google Scholar 

  78. Said MH, Layani MP, Colon S, Faraj G, Glastre C, Cochat P. Mycoplasma pneumoniae-associated nephritis in children. Pediatr Nephrol. 1999;13:39–44.

    Article  CAS  PubMed  Google Scholar 

  79. Suzuki K, Hirano K, Onodera N, Takahashi T, Tanaka H. Acute IgA nephropathy associated with Mycoplasma pneumoniae infection. Pediatr Int. 2005;47:583–5.

    Article  PubMed  Google Scholar 

  80. Mizutani H, Mizutani H. Circulating immune complexes in patients with mycoplasmal pneumonia. Am Rev Respir Dis. 1984;130:627–9.

    CAS  PubMed  Google Scholar 

  81. Biberfeld G, Norberg R. Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol. 1974;112:413–5.

    CAS  PubMed  Google Scholar 

  82. Hirshberg SJ, Charles RS, Ettinger JB. Pediatric priapism associated with Mycoplasma pneumoniae. Urology. 1996;47:745–6.

    Article  CAS  PubMed  Google Scholar 

  83. Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis. 2008;198:1180–8.

    Article  CAS  PubMed  Google Scholar 

  84. Amsden GW. Anti-inflammatory effects of macrolides––an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother. 2005;55:10–21.

    Article  CAS  PubMed  Google Scholar 

  85. Barile MF, Kapatais-Zoumbos K, Snoy P, Grabowski MW, Sneller M, Miller L, et al. Experimentally induced septic arthritis in chimpanzees infected with Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum. Clin Infect Dis. 1994;18:694–703.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsuo Narita.

About this article

Cite this article

Narita, M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 16, 162–169 (2010). https://doi.org/10.1007/s10156-010-0044-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-010-0044-x

Keywords

  • Immune response
  • Hematogenous dissemination
  • Cytokine
  • Autoimmunity
  • Hypercoagulation
  • Vascular occlusion